A detailed history of Royal Bank Of Canada transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 15,137 shares of IRWD stock, worth $59,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,137
Previous 14,003 8.1%
Holding current value
$59,942
Previous $91,000 31.87%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.93 - $7.04 $4,456 - $7,983
1,134 Added 8.1%
15,137 $62,000
Q2 2024

Aug 14, 2024

BUY
$5.58 - $8.61 $31,739 - $48,973
5,688 Added 68.41%
14,003 $91,000
Q1 2024

Nov 05, 2024

SELL
$8.32 - $15.45 $47,324 - $87,879
-5,688 Reduced 40.62%
8,315 $72,000
Q1 2024

May 15, 2024

SELL
$8.32 - $15.45 $303,788 - $564,125
-36,513 Reduced 81.45%
8,315 $72,000
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $195,225 - $255,637
22,210 Added 98.2%
44,828 $512,000
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $74,959 - $103,126
9,086 Added 67.14%
22,618 $217,000
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $39,612 - $45,495
3,922 Added 40.81%
13,532 $143,000
Q1 2023

May 15, 2023

SELL
$10.37 - $12.56 $170,068 - $205,984
-16,400 Reduced 63.05%
9,610 $101,000
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $217,265 - $272,788
21,946 Added 540.01%
26,010 $322,000
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $18,779 - $22,927
-1,852 Reduced 31.3%
4,064 $42,000
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $98,356 - $113,220
-8,901 Reduced 60.07%
5,916 $69,000
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $285,599 - $346,703
-26,918 Reduced 64.5%
14,817 $186,000
Q4 2021

Feb 14, 2022

SELL
$10.86 - $13.95 $123,532 - $158,681
-11,375 Reduced 21.42%
41,735 $487,000
Q3 2021

Nov 15, 2021

BUY
$11.92 - $13.92 $309,991 - $362,003
26,006 Added 95.95%
53,110 $693,000
Q2 2021

Aug 16, 2021

BUY
$10.16 - $13.11 $275,376 - $355,333
27,104 New
27,104 $349,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $607M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.